caggs multiple cloning site (Azenta)
90
Structured Review
Azenta
caggs multiple cloning site
Caggs Multiple Cloning Site, supplied by Azenta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/caggs+multiple+cloning+site/caggs+multiple+cloning+site/10__1158_slash_2159___8290__cd___24___0614-355-12-19
Average 90 stars, based on 1 article reviews
Caggs Multiple Cloning Site, supplied by Azenta, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/caggs+multiple+cloning+site/caggs+multiple+cloning+site/10__1158_slash_2159___8290__cd___24___0614-355-12-19
Average 90 stars, based on 1 article reviews
caggs multiple cloning site - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Construct:Article Title: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Article Snippet: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Michelangelo Marasco1, Dinesh Kumar1, Santiago Garcia Borrego2, Tessa Seale2, Giulia Maddalena3,4,5, Riccardo Mezzadra6, Kylie Belanger2,7,8, Soren Cole2, Brayan Perez2,7,8, Wei Luan6, Radha Mukherjee1, Ilinca Aricescu1, Vladimir Markov9, Yuxin Zhu9, Sabrina Arena10,11, Alberto Bardelli12,13, Elisa de Stanchina9, Scott W. Lowe6, Richard A. Burkhart2,14, Jacquelyn W. Zimmerman2,8, Rona Yaeger15, Scott E. Kopetz3, Neal Rosen1,15, and Sandra Misale2 D ow nloaded from http://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.C D -24-0614/3599494/cd-24-0614.pdf by guest on 01 M ay 2025 AACRJournals.orgOF2 | CANCER DISCOVERY XXX 2025 intRoduction RAS GTPases (KRAS, NRAS, and HRAS) are molecular switches that regulate cell proliferation and survival in response to receptor tyrosine kinase (RTK) activation (1).. In normal cells, RAS proteins alternate between an inactive GDP-bound form and an active GTP-bound form.. RAS cycling is regulated by GTPase-activating proteins (GAP), which catalyze the hydrolysis of RAS-bound GTP, and guanine nucleotide exchange factors, which promote the dissociation of GDP from RAS, allowing its reloading with GTP (2). Cloning:Article Title: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Article Snippet: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Michelangelo Marasco1, Dinesh Kumar1, Santiago Garcia Borrego2, Tessa Seale2, Giulia Maddalena3,4,5, Riccardo Mezzadra6, Kylie Belanger2,7,8, Soren Cole2, Brayan Perez2,7,8, Wei Luan6, Radha Mukherjee1, Ilinca Aricescu1, Vladimir Markov9, Yuxin Zhu9, Sabrina Arena10,11, Alberto Bardelli12,13, Elisa de Stanchina9, Scott W. Lowe6, Richard A. Burkhart2,14, Jacquelyn W. Zimmerman2,8, Rona Yaeger15, Scott E. Kopetz3, Neal Rosen1,15, and Sandra Misale2 D ow nloaded from http://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.C D -24-0614/3599494/cd-24-0614.pdf by guest on 01 M ay 2025 AACRJournals.orgOF2 | CANCER DISCOVERY XXX 2025 intRoduction RAS GTPases (KRAS, NRAS, and HRAS) are molecular switches that regulate cell proliferation and survival in response to receptor tyrosine kinase (RTK) activation (1).. In normal cells, RAS proteins alternate between an inactive GDP-bound form and an active GTP-bound form.. RAS cycling is regulated by GTPase-activating proteins (GAP), which catalyze the hydrolysis of RAS-bound GTP, and guanine nucleotide exchange factors, which promote the dissociation of GDP from RAS, allowing its reloading with GTP (2). Synthesized:Article Title: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Article Snippet: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Michelangelo Marasco1, Dinesh Kumar1, Santiago Garcia Borrego2, Tessa Seale2, Giulia Maddalena3,4,5, Riccardo Mezzadra6, Kylie Belanger2,7,8, Soren Cole2, Brayan Perez2,7,8, Wei Luan6, Radha Mukherjee1, Ilinca Aricescu1, Vladimir Markov9, Yuxin Zhu9, Sabrina Arena10,11, Alberto Bardelli12,13, Elisa de Stanchina9, Scott W. Lowe6, Richard A. Burkhart2,14, Jacquelyn W. Zimmerman2,8, Rona Yaeger15, Scott E. Kopetz3, Neal Rosen1,15, and Sandra Misale2 D ow nloaded from http://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.C D -24-0614/3599494/cd-24-0614.pdf by guest on 01 M ay 2025 AACRJournals.orgOF2 | CANCER DISCOVERY XXX 2025 intRoduction RAS GTPases (KRAS, NRAS, and HRAS) are molecular switches that regulate cell proliferation and survival in response to receptor tyrosine kinase (RTK) activation (1).. In normal cells, RAS proteins alternate between an inactive GDP-bound form and an active GTP-bound form.. RAS cycling is regulated by GTPase-activating proteins (GAP), which catalyze the hydrolysis of RAS-bound GTP, and guanine nucleotide exchange factors, which promote the dissociation of GDP from RAS, allowing its reloading with GTP (2). Clone Assay:Article Title: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Article Snippet: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations Michelangelo Marasco1, Dinesh Kumar1, Santiago Garcia Borrego2, Tessa Seale2, Giulia Maddalena3,4,5, Riccardo Mezzadra6, Kylie Belanger2,7,8, Soren Cole2, Brayan Perez2,7,8, Wei Luan6, Radha Mukherjee1, Ilinca Aricescu1, Vladimir Markov9, Yuxin Zhu9, Sabrina Arena10,11, Alberto Bardelli12,13, Elisa de Stanchina9, Scott W. Lowe6, Richard A. Burkhart2,14, Jacquelyn W. Zimmerman2,8, Rona Yaeger15, Scott E. Kopetz3, Neal Rosen1,15, and Sandra Misale2 D ow nloaded from http://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.C D -24-0614/3599494/cd-24-0614.pdf by guest on 01 M ay 2025 AACRJournals.orgOF2 | CANCER DISCOVERY XXX 2025 intRoduction RAS GTPases (KRAS, NRAS, and HRAS) are molecular switches that regulate cell proliferation and survival in response to receptor tyrosine kinase (RTK) activation (1).. In normal cells, RAS proteins alternate between an inactive GDP-bound form and an active GTP-bound form.. RAS cycling is regulated by GTPase-activating proteins (GAP), which catalyze the hydrolysis of RAS-bound GTP, and guanine nucleotide exchange factors, which promote the dissociation of GDP from RAS, allowing its reloading with GTP (2). |